Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Int J Tuberc Lung Dis ; 26(9): 842-849, 2022 09 01.
Article in English | MEDLINE | ID: mdl-35996280

ABSTRACT

BACKGROUND: TB in low-incidence countries is characterised by changes in age distribution towards larger numbers of cases among the elderly.OBJECTIVES: To investigate clinical features and outcomes of TB treatment in older patients and identify predictors of poor outcome.METHODS: Multicentre retrospective study of new TB cases from 53 hospitals included in the registry of the Integrated Tuberculosis Research Programme of the Spanish Society of Pulmonology and Thoracic Surgery (Sociedad Española de Neumología y Cirugía Torácica) between 2006 and 2020.RESULTS: We identified 731 patients aged ≥75 years from a cohort of 7,505 patients with TB. In the elderly, weight loss, disseminated disease and normal X-rays or infiltrates without cavitation were more common. All-cause mortality was 16% (5% of deaths due to TB). The elderly had higher rates of toxicity (6.7%) and hospital admissions (36%). In the multivariate analysis of predictors of TB mortality in ≥75-year-olds, only weight, age and treatment with non-standard regimens remained significant.CONCLUSIONS: TB in older patients needs more attention and remains a challenge because of a lack of specific clinical and radiological features. Standard treatment is effective, although mortality is higher than in young patients. Low weight, non-standard regimens and age are significant predictors of TB mortality.


Subject(s)
Pulmonary Medicine , Thoracic Surgery , Tuberculosis , Age Distribution , Aged , Humans , Retrospective Studies , Tuberculosis/diagnosis , Tuberculosis/drug therapy , Tuberculosis/epidemiology
2.
Genomics ; 113(4): 2240-2252, 2021 07.
Article in English | MEDLINE | ID: mdl-34015461

ABSTRACT

The vomeronasal organ (VNO) is a chemosensory organ specialized in pheromone detection that shows a broad morphofunctional and genomic diversity among mammals. However, its expression patterns have only been well-characterized in mice. Here, we provide the first comprehensive RNA sequencing study of the rabbit VNO across gender and sexual maturation stages. We characterized the VNO transcriptome, updating the number and expression of the two main vomeronasal receptor families, including 128 V1Rs and 67 V2Rs. Further, we defined the expression of formyl-peptide receptor and transient receptor potential channel families, both known to have specific roles in the VNO. Several sex hormone-related pathways were consistently enriched in the VNO, highlighting the relevance of this organ in reproduction. Moreover, whereas juvenile and adult VNOs showed significant transcriptome differences, male and female did not. Overall, these results contribute to understand the genomic basis of behavioural responses mediated by the VNO in a non-rodent model.


Subject(s)
Vomeronasal Organ , Animals , Female , Male , Mammals/genetics , Mice , Pheromones , Rabbits , Receptors, Formyl Peptide/genetics , Transcriptome , Vomeronasal Organ/metabolism
3.
J Int Soc Sports Nutr ; 13: 10, 2016.
Article in English | MEDLINE | ID: mdl-26957952

ABSTRACT

BACKGROUND: It is habitual for combat sports athletes to lose weight rapidly to get into a lower weight class. Fluid restriction, dehydration by sweating (sauna or exercise) and the use of diuretics are among the most recurrent means of weight cutting. Although it is difficult to dissuade athletes from this practice due to the possible negative effect of severe dehydration on their health, athletes may be receptive to avoid weight cutting if there is evidence that it could affect their muscle performance. Therefore, the purpose of the present study was to investigate if hypohydration, to reach a weight category, affects neuromuscular performance and combat sports competition results. METHODS: We tested 163 (124 men and 39 woman) combat sports athletes during the 2013 senior Spanish National Championships. Body mass and urine osmolality (UOSM) were measured at the official weigh-in (PRE) and 13-18 h later, right before competing (POST). Athletes were divided according to their USOM at PRE in euhydrated (EUH; UOSM 250-700 mOsm · kgH2O(-1)), hypohydrated (HYP; UOSM 701-1080 mOsm · kgH2O(-1)) and severely hypohydrated (S-HYP; UOSM 1081-1500 mOsm · kgH2O(-1)). Athletes' muscle strength, power output and contraction velocity were measured in upper (bench press and grip) and lower body (countermovement jump - CMJ) muscle actions at PRE and POST time-points. RESULTS: At weigh-in 84 % of the participants were hypohydrated. Before competition (POST) UOSM in S-HYP and HYP decreased but did not reach euhydration levels. However, this partial rehydration increased bench press contraction velocity (2.8-7.3 %; p < 0.05) and CMJ power (2.8 %; p < 0.05) in S-HYP. Sixty-three percent of the participants competed with a body mass above their previous day's weight category and 70 of them (69 % of that sample) obtained a medal. CONCLUSIONS: Hypohydration is highly prevalent among combat sports athletes at weigh-in and not fully reversed in the 13-18 h from weigh-in to competition. Nonetheless, partial rehydration recovers upper and lower body neuromuscular performance in the severely hypohydrated participants. Our data suggest that the advantage of competing in a lower weight category could compensate the declines in neuromuscular performance at the onset of competition, since 69 % of medal winners underwent marked hypohydration.


Subject(s)
Athletes , Athletic Performance/physiology , Competitive Behavior , Dehydration/physiopathology , Weight Loss , Adult , Athletes/psychology , Athletic Performance/psychology , Body Weight , Boxing , Dehydration/urine , Female , Humans , Male , Martial Arts , Muscle Contraction , Osmolar Concentration , Prevalence , Sweating , Thirst , Urinalysis , Water-Electrolyte Balance , Wrestling
4.
Vet Microbiol ; 178(3-4): 208-16, 2015 Aug 05.
Article in English | MEDLINE | ID: mdl-26009303

ABSTRACT

Despite the success of vaccination against myxoma virus, myxomatosis remains a problem on rabbit farms throughout Spain and Europe. In this study we set out to evaluate possible causes of myxoma virus (MYXV) vaccine failures addressing key issues with regard to pathogen, vaccine and vaccination strategies. This was done by genetically characterising MYXV field isolates from farm outbreaks, selecting a representative strain for which to assay its virulence and measuring the protective capability of a commercial vaccine against this strain. Finally, we compare methods (route) of vaccine administration under farm conditions and evaluate immune response in vaccinated rabbits. The data presented here show that the vaccine tested is capable of eliciting protection in rabbits that show high levels of seroconversion. However, the number of animals failing to seroconvert following subcutaneous vaccination may leave a large number of rabbits unprotected following vaccine administration. Successful vaccination requires the strict implication of workable, planned, on farm programs. Following this, analysis to confirm seroconversion rates may be advisable. Factors such as the wild rabbit reservoir, control of biting insects and good hygienic practices must be taken into consideration to prevent vaccine failures from occurring.


Subject(s)
Disease Outbreaks/veterinary , Myxoma virus/immunology , Myxomatosis, Infectious/epidemiology , Vaccination/veterinary , Viral Vaccines/immunology , Animal Husbandry , Animals , Base Sequence , Geography , Molecular Sequence Data , Myxoma virus/classification , Myxoma virus/genetics , Myxomatosis, Infectious/prevention & control , Rabbits , Sequence Analysis, DNA/veterinary , Spain/epidemiology , Virulence
5.
Rev. clín. esp. (Ed. impr.) ; 212(1): 18-23, ene. 2012.
Article in Spanish | IBECS | ID: ibc-94035

ABSTRACT

Antecedentes y objetivo. En las últimas décadas se han descrito variaciones en la epidemiología del carcinoma de pulmón. Hemos analizado si se han producido cambios en la epidemiología y la supervivencia del carcinoma de pulmón. Pacientes y métodos. Se incluyeron todos los casos con el diagnóstico de carcinoma de pulmón, con confirmación citohistológica entre mayo de 1997 y diciembre de 2008. Para comparar las variables analizadas se dividió el período de estudio en tres cohortes comprendidas respectivamente entre los años 1997-2000, 2001-2004 y 2005-2008. Resultados. Se incluyeron 905 pacientes, 776 varones (85,7%), con una edad media (± DE) de 64,4±11,6 años. El número de mujeres se incrementó desde el 11,2% en 1997-2000 hasta el 16,2% en 2005-2008. La estirpe adenocarcinoma aumentó desde el 29,3% en 1997-2000 hasta el 34,5% en 2005-2008 (p=0,02). La mediana de supervivencia se incrementó en 10 semanas: 51 semanas en 1997-2000 y 61 semanas en 2005-2008 (p=0,2). La supervivencia se asoció de forma independiente con el grado de actividad, tratamiento recibido, comorbilidad y pérdida de peso. Conclusiones. En nuestra área se ha producido un incremento del número de casos de cáncer de pulmón en las mujeres. Ha aumentado el tipo histológico de adenocarcinoma, y apreciamos un leve aumento de la supervivencia(AU)


Background and objective. In the last decades, variations have been described in the epidemiology of lung cancer. In our study, we have analyzed if changes have occurred in the epidemiology and survival of lung cancer. Patients and methods. All the cases with the diagnosis of lung cancer having cytohistological confirmation between May 1997 and December 2008 were included. To compare the variables, the study period was divided into three cohorts, respectively including the years 1997-2000, 2001-2004 and 2005-2008. Results. A total of 905 patients, 776 males (85.7%) were included with a mean age (± SD) of 64.4±11.6 years. The number of cases in females went from 11.2% in 1997-2000 to 16.2% in 2005-2008, and adenocarcinoma from 29.3% to 34.5% (P=.2). Survival was associated independently with the performance status, treatment, comorbidity and weight loss. Conclusions. In our area, there is been an increasing number of cases of lung cancer in females. The histological type of adenocarcinoma has increased and we have observed a slight increase in survival(AU)


Subject(s)
Humans , Male , Female , Lung Neoplasms/epidemiology , Carcinoma/complications , Carcinoma/epidemiology , Carcinoma, Bronchogenic/complications , Carcinoma, Bronchogenic/epidemiology , Survivorship , Cohort Studies , Linear Models
6.
Rev Clin Esp ; 212(1): 18-23, 2012 Jan.
Article in Spanish | MEDLINE | ID: mdl-22206930

ABSTRACT

BACKGROUND AND OBJECTIVE: In the last decades, variations have been described in the epidemiology of lung cancer. In our study, we have analyzed if changes have occurred in the epidemiology and survival of lung cancer. PATIENTS AND METHODS: All the cases with the diagnosis of lung cancer having cytohistological confirmation between May 1997 and December 2008 were included. To compare the variables, the study period was divided into three cohorts, respectively including the years 1997-2000, 2001-2004 and 2005-2008. RESULTS: A total of 905 patients, 776 males (85.7%) were included with a mean age (± SD) of 64.4 ± 11.6 years. The number of cases in females went from 11.2% in 1997-2000 to 16.2% in 2005-2008, and adenocarcinoma from 29.3% to 34.5% (P=.2). Survival was associated independently with the performance status, treatment, comorbidity and weight loss. CONCLUSIONS: In our area, there is been an increasing number of cases of lung cancer in females. The histological type of adenocarcinoma has increased and we have observed a slight increase in survival.


Subject(s)
Adenocarcinoma/epidemiology , Lung Neoplasms/epidemiology , Adenocarcinoma/mortality , Aged , Carcinoma, Large Cell/epidemiology , Carcinoma, Large Cell/mortality , Carcinoma, Squamous Cell/epidemiology , Carcinoma, Squamous Cell/mortality , Female , Humans , Lung Neoplasms/mortality , Male , Middle Aged , Retrospective Studies , Sex Distribution , Spain/epidemiology , Survival Analysis
7.
Lung Cancer ; 71(2): 182-5, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20554345

ABSTRACT

BACKGROUND AND OBJECTIVE: It has been reported that the presence of COPD and emphysema is associated with an increased risk of lung cancer, but the prognosis significance of these two conditions is not well known. The aim of our study was to analyze the influence of COPD and emphysema in the prognosis of non-small cell lung cancer (NSCLC). METHODS: Three hundred and fifty-three patients with cytohistologic diagnosis of NSCLC were prospectively collected. The relationship between survival at two years and the following variables: age, sex, smoking habit, comorbid diseases (cardiovascular diseases, previous tumour and COPD), weight loss, presence of emphysema on CT scan, performance status (PS) and treatment, was analyzed. The Kaplan-Meier method and log-rank test were used for survival analysis. A multivariate Cox proportional hazard model, stratified by TNM stage, was used to evaluate prognostic factors. RESULTS: Emphysema was present in 110 patients, associated with COPD in 78 (70.9%). In univariate analysis, survival decreased with age>70 years (p=0.01), presence of emphysema (p=0.02), weight loss (p=0.00001), PS≥2 (p=0.00001) and symptomatic treatment (p=0.0001). Multivariate analyses identified emphysema (HR=1.49 (95% CI 1.11-2.01)), PS≥2 (HR=2.12 (95% CI 1.31-3.38)) and treatment: surgery (HR=0.3 (95% CI 0.15-0.56)) and chemotherapy (HR=0.34 (95% CI 0.31-0.57)) as independent prognostic factors. CONCLUSION: The presence of emphysema affects the prognostic outcome of patients with non-small cell lung cancer. Emphysema should therefore be considered for prognostic studies on comorbidity.


Subject(s)
Airway Obstruction/complications , Carcinoma, Non-Small-Cell Lung/complications , Carcinoma, Non-Small-Cell Lung/mortality , Lung Neoplasms/complications , Lung Neoplasms/mortality , Pulmonary Emphysema/complications , Adult , Aged , Aged, 80 and over , Carcinoma, Non-Small-Cell Lung/pathology , Comorbidity , Female , Humans , Lung Neoplasms/pathology , Male , Middle Aged , Neoplasm Staging , Prognosis , Pulmonary Disease, Chronic Obstructive/complications , Survival Analysis
8.
Monaldi Arch Chest Dis ; 71(3): 127-31, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19999959

ABSTRACT

BACKGROUND AND OBJECTIVE: It has been reported that tobacco smoking slows the sterilisation of sputum culture in pulmonary tuberculosis, but the factors that could delay culture conversion in patients who smoke are not known. Our aim is to identify the factors influencing sputum culture conversion in smokers with pulmonary tuberculosis. METHODS: Ninety-nine patients with a smoking history and diagnosed with pulmonary tuberculosis were analysed retrospectively. The relationship between sputum culture status at the second month and the following variables: age, gender, pack-years index, comorbid diseases, number acid-fast bacilli (AFB) in sputum smear examination, radiological findings (cavitary, extensive or limited disease), drug susceptibility pattern and initial treatment, was analysed. The Student t-test, chi-square test and logistic regression model with forward stepwise conditional methods were used for statistical analysis. A p value of <0.05 was considered to be statistically significant. RESULTS: Twenty six patients (26.2%): 18 males (22.2%) and 8 females (44%) were sputum culture positive at the end of the second month of treatment. In univariate analysis, culture conversion time was significantly associated with female gender and extensive disease, but in a logistic regression analysis was only correlated with female gender (OR=5.63 95% CI 1.21-20.64-p=0.02). CONCLUSION: In current smokers with pulmonary tuberculosis, the 'time to culture' conversion relates only to the female gender.


Subject(s)
Mycobacterium tuberculosis/isolation & purification , Smoking/adverse effects , Sputum/microbiology , Tuberculosis, Pulmonary/microbiology , Adult , Chi-Square Distribution , Data Interpretation, Statistical , Female , Humans , Logistic Models , Male , Middle Aged , Mycobacterium tuberculosis/growth & development , Randomized Controlled Trials as Topic , Retrospective Studies , Sex Factors , Time Factors , Tuberculosis, Pulmonary/drug therapy
9.
J Nanosci Nanotechnol ; 9(4): 2256-73, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19437963

ABSTRACT

Gold nanoparticles of different shapes/surface structures were synthesized and electrochemically characterized. An in-situ surface characterization of the Au nanoparticles, which was able to obtain qualitative information about the type and relative sizes of the different facets present in the surface of the Au nanoparticles, was carried out by using Pb Under Potential Deposition (UPD) in alkaline solutions as a surface sensitive tool. The results obtained show that the final atomic arrangement on the surface can be different from that expected from the bulk structure of the well-defined shape Au nanoparticles. In this way, the development of precise in-situ methods to measure the distribution of the different sites on the nanoparticle surface, as lead UPD on gold surfaces, is highlighted. Oxygen Reduction Reaction (ORR) was performed on the different Au nanoparticles. In agreement with the particular sensitivity of the oxygen reduction to the presence of Au(100) surface domains, cubic Au nanoparticles show much better electrocatalytic activity for ORR than small spherical particles and long nanorods, in agreement with the presence of a great fraction of (100) terrace sites on the surface of cubic gold nanoparticles.

10.
Reprod Domest Anim ; 44(5): 829-33, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19000226

ABSTRACT

This study was aimed to evaluate the reproductive performance of rabbit does artificially inseminated (AI) with a GnRH analogue [des-Gly10, D-Ala6]-LHRH. ethylamide to induce ovulation by intravaginal administration, delivered in the seminal dose. In a preliminary experiment, 39 does were divided into three groups (n = 13) that, at the time of AI, received the following ovulation induction treatments: (i) control group: 20 microg of gonadorelin administered intramuscularly; (ii) 25 microg of the GnRH analogue added to the seminal dose; (iii) 30 microg of the GnRH analogue added to the seminal dose. Fertility did not differ between the three groups (control: 80.6%, group 2: 82.8%, group 3: 73.3%). In a second experiment, a large-scale field trial was conducted to test the use of 25 microg of the GnRH analogue [des-Gly10, D-Ala6]-LHRH ethylamide delivered in the seminal dose (n = 270) against 20 microg of gonadorelin administered intramuscularly. Fertility was higher (p < 0.05) when ovulation was induced by intravaginal administration of the GnRH agonist (91.1% vs 85.6%). Prolificacy or mortality at birth was never affected by the ovulation induction treatments. In a third experiment, two groups of does [control group (n = 39): ovulation was induced using 20 microg of gonadorelin administered intramuscularly; treatment group (n = 40): ovulation was induced using 25 microg of [(des-Gly10, D-Ala6)-LHRH ethylamide added to the seminal dose] were inseminated at 42-day intervals for five successive AI cycles, to test the response to the GnRH agonist after repeated intravaginal administration to the same animals. Fertility and prolificacy were not influenced by the ovulation induction treatment neither there was an interaction between treatment and parity. The last experiment was aimed to determine whether it could be possible to add the GnRH agonist to the semen in the AI Center, just after semen collection and dilution, or it would have to be added in the farm, immediately before AI. Kindling rates did not significantly differ when ovulation was induced by intramuscular injection of gonadorelin (84.5%) or when the GnRH agonist was added to the seminal dose just at the moment (93.8 %) or 24 h before AI (90.4 %), but it was significantly lower when the hormone was added to the semen 32 h before AI (76.3 %). Prolificacy, however, was not influenced by the ovulation induction treatment.


Subject(s)
Gonadotropin-Releasing Hormone/analogs & derivatives , Gonadotropin-Releasing Hormone/agonists , Insemination, Artificial/veterinary , Ovulation Induction/veterinary , Rabbits/physiology , Reproduction/physiology , Administration, Intravaginal , Animals , Female , Gonadotropin-Releasing Hormone/administration & dosage , Insemination, Artificial/methods , Male , Ovulation Induction/methods , Pregnancy
11.
Phys Chem Chem Phys ; 10(25): 3689-98, 2008 Jul 07.
Article in English | MEDLINE | ID: mdl-18563230

ABSTRACT

Reactivity towards methanol and formic acid electrooxidation on Pt nanoparticles with well characterised surfaces were studied and compared with the behaviour of single crystal electrodes with basal orientations. Polyoriented and preferential (100), (111) and (100)-(111) Pt nanoparticles were synthesised, cleaned preserving its surface structure, characterised and employed to evaluate the influence of the surface structure/shape of the Pt nanoparticles on these two relevant electrochemical reactions. The results pointed out that, in agreement with fundamental studies with Pt single crystal electrodes, the surface structure of the electrodes plays an important role on the reactivity of both oxidation processes, and thus the electrocatalytic properties strongly depend on the surface structure/shape of the nanoparticles, in particular on the presence of sites with (111) symmetry. These findings open the possibility of designing new and better electrocatalytic materials using decorated shape-controlled Pt nanoparticles as previously described with Pt single crystal electrodes.


Subject(s)
Formates/chemistry , Metal Nanoparticles/chemistry , Methanol/chemistry , Platinum/chemistry , Adsorption , Carbon Monoxide/chemistry , Catalysis , Electrochemistry , Electrodes , Microscopy, Electron, Transmission , Oxidation-Reduction , Sulfuric Acids/chemistry , Surface Properties
12.
Anim Reprod Sci ; 103(3-4): 385-91, 2008 Jan 30.
Article in English | MEDLINE | ID: mdl-17573211

ABSTRACT

The possibility of modifying the sex ratio of rabbit litters was examined in two experiments involving artificial insemination (AI) with fresh semen. Three time periods of AI, relative to ovulation, were used in Experiment 1: (a) control, GnRH was administered immediately after AI with ovulation estimated to occur 10-12h after AI; (b) early AI, GnRH was given 6h after AI so that ovulation was delayed until 16-18 h after AI; (c) late AI, GnRH was administered 6h before AI, which was performed 4-6h before ovulation. There were 13 does per treatment, and each doe was used in the same treatment for three AIs at 42-day intervals. The second experiment involved two treatments in which the does were inseminated as for the control in Experiment 1 and AI was performed using semen prepared in the normal manner (Treatment 1) or after centrifugation through 11 discontinuous Percoll gradients (Treatment 2). There were 20 does per treatment, and each doe was used in the same treatment for three AIs at 42-day intervals. The proportion of female kits produced in Experiment 1 was: control 41.7+/-19.1%, early AI 49.8+/-17.8%, and late AI 41.4+/-16.4%. These proportions did not differ significantly between treatments or from the expected 50:50 sex ratio. Fertility was reduced by the early (60.0%) and late (73.7%) AI treatments relative to control AI (80.0%), and the difference between early and control AI almost achieved statistical significance (P<0.07). In Experiment 2, the proportion of female kits was not affected by treatment (control, 51.1%; Percoll, 54.8%), and there was a similar level of fertility for both treatments (control, 76.0%; Percoll, 74.1%). Prolificacy and perinatal mortality were not affected by treatment in either experiment. It was concluded that neither the timing of insemination nor Percoll centrifugation of semen affected the sex ratio at birth of rabbit litters.


Subject(s)
Insemination, Artificial/veterinary , Rabbits/physiology , Sex Ratio , Animal Husbandry , Animals , Female , Fertility/drug effects , Male , Povidone/toxicity , Pregnancy , Random Allocation , Sex Preselection/veterinary , Silicon Dioxide/toxicity , Time Factors
13.
Arch Bronconeumol ; 39(11): 496-500, 2003 Nov.
Article in Spanish | MEDLINE | ID: mdl-14588202

ABSTRACT

BACKGROUND: Transbronchial needle aspiration (TBNA) is a bronchoscopic technique whose usefulness in diagnosing endobronchial lesions has not yet been clearly established. OBJECTIVE: We aimed to determine whether the diagnostic yield of fiberoptic bronchoscopy could be increased, without a negative impact on diagnostic costs, if TBNA were used in combination with conventional diagnostic techniques (bronchial washings and bronchial brushings and forceps biopsy). PATIENTS AND METHODS: The cases of 130 patients diagnosed with bronchogenic carcinoma with endoscopically visible lesions were analyzed retrospectively. All had undergone conventional diagnostic procedures; TBNA was also performed if the bronchoscopist considered it was indicated. The final cost was calculated in euros for each diagnosis as the sum of the cost of the procedures needed to reach the diagnosis, including both endoscopic procedures and others (transthoracic needle aspiration, lymph node biopsy). Diagnostic yield and costs in cases diagnosed using only conventional techniques were compared to the yield and costs in cases in which both conventional techniques and TBNA were used. RESULTS: TBNA was performed in 49 patients and provided the diagnosis in 85.7%. Conventional techniques led to cytological and histological diagnosis in 80.2% of the cases, and the combination of conventional techniques and TBNA gave a diagnosis in 89.7% (P=.01). Significant differences were observed in extrinsic compression (conventional 37.5%; conventional+TBNA 100%; P=.01), submucosal infiltration (conventional 54.6%; conventional+TBNA 85%; P=.03), and exophytic mass with necrosis (conventional 80%; conventional+TBNA 100%; P=.01). The mean (SD) cost of diagnosis was euros 381.60 (euros 156.53) using conventional techniques and euros 413.25 (euros 112.91) for conventional techniques in combination with TBNA. By adding TBNA, costs decreased for diagnoses of submucosal infiltration, exophytic mass with necrosis and extrinsic compression, although the saving was significant only for extrinsic compression. CONCLUSION: The diagnostic yield of TBNA is high for endoscopically visible bronchial anomalies suggesting neoplasm, particularly when the lesion is due to extrinsic compression, submucosal infiltration, or exophytic mass with necrosis.


Subject(s)
Biopsy, Needle/economics , Carcinoma, Bronchogenic/pathology , Lung Neoplasms/pathology , Biopsy, Needle/methods , Biopsy, Needle/statistics & numerical data , Bronchi , Bronchoscopy , Cost-Benefit Analysis , Female , Humans , Male , Middle Aged , Retrospective Studies
14.
Arch. bronconeumol. (Ed. impr.) ; 39(11): 496-500, nov. 2003.
Article in Es | IBECS | ID: ibc-24034

ABSTRACT

FUNDAMENTO: La punción transbronquial (PTB) es una técnica broncoscópica cuya utilidad en tumores con lesión endobronquial no está claramente establecida.OBJETIVO: Con nuestro trabajo pretendemos estudiar si la combinación de la PTB con las técnicas diagnósticas convencionales (aspirado, cepillado y biopsia bronquiales) incrementa el rendimiento de la fibrobroncoscopia, sin repercutir negativamente en el coste económico (CE) del proceso diagnóstico. PACIENTES Y MÉTODOS: Se analizó de forma retrospectiva a 130 pacientes diagnosticados de carcinoma broncogénico con lesión endoscópica visible, a quienes se les practicaron las técnicas convencionales, quedando a criterio del broncoscopista responsable la realización de PTB. Se calculó el coste final por proceso, en euros, constituido por la suma del coste de los procedimientos necesarios para lograr el diagnóstico, en los que se incluían los endoscópicos y otros (punción transtorácica, punción-biopsia ganglionar). Se compararon el rendimiento y el CE entre el grupo de pacientes a los que se practicaron las técnicas convencionales (ACB) y aquellos a los que se añadió PTB (ACB + PTB). RESULTADOS: La PTB se realizó en 49 pacientes y proporcionó el diagnóstico de naturaleza en el 85,7 por ciento de los casos. Con ACB se logró la filiación citohistológica en el 80,2 por ciento de los casos, y en el 89,7 por ciento con ACB + PTB (p = 0,01); se apreciaron diferencias significativas en: compresión extrínseca (ACB: 37,5 por ciento; ACB + PTB: 100 por ciento; p = 0,01), infiltración submucosa (ACB: 54,6 por ciento; ACB + PTB: 85 por ciento; p = 0,03) y masa exofítica con necrosis (ACB: 80 por ciento; ACB + PTB: 100 por ciento; p = 0,01). El CE medio fue de 381,60 ñ 156,53 euros en ACB y 413,25 ñ 112,91 en ACB + PTB; al añadir la PTB se redujo el CE en infiltración submucosa, masa exofítica con necrosis y compresión extrínseca, aunque este ahorro sólo resultó significativo en compresión extrínseca. CONCLUSIÓN: La punción transbronquial es una técnica de elevada rentabilidad en presencia de anomalías endobronquiales indicativas de neoformación, particularmente cuando la lesión visualizada corresponde a compresión extrínseca, infiltración submucosa o masa exofítica con superficie necrótica (AU)


Subject(s)
Middle Aged , Male , Female , Humans , Retrospective Studies , Biopsy, Needle , Bronchi , Carcinoma, Bronchogenic , Bronchoscopy , Cost-Benefit Analysis , Lung Neoplasms
15.
Arch Bronconeumol ; 37(11): 477-81, 2001 Dec.
Article in Spanish | MEDLINE | ID: mdl-11734136

ABSTRACT

UNLABELLED: This study of advanced-stage non-small cell bronchogenic carcinoma aimed 1) to identify prognostic factors collected at the moment of diagnosis, 2) to determine whether weight loss is a useful parameter to screen for subjects who will receive greater benefit from anticancer therapy.Patients and methods. Eighty-one patients were enrolled after diagnosis of stage III-B and IV non-small cell bronchogenic carcinoma and levels of activity < 2 according to Eastern Co-operative Oncology Group classification. The variables studied were age, sex, smoking history, associated disease, clinical data (weight loss, dyspnea, superior vena cava syndrome), laboratory parameters [hemoglobin, serum albumin, total lymphocytes, serum lactate dehydrogenase (LDH), calcium and liver enzymes], tumor-node-metastasis (TNM) staging, histologic type, activity, treatment received and survival in weeks. The results were analyzed in two groups: 1) the general group consisting of results for all patients, and 2) the no-weight-loss group consisting of results for those whose weight had been stable. Student t, chi-squared, Kaplan Meier, log-rank and Cox's regression model were used to analyze data and survival. RESULTS: Mean survival was 29 weeks (21-37). Survival was significantly related to weight loss, total lymphocytes, serum LDH, TNM and activity level in the general group. Only two factors continued to have prognostic value in the multivariate study: weight loss (OR: 1.48 (1.14-1.92), p = 0.002) and TNM (OR: 0.72 (0.54-0.96), p = 0.02). Among the patients with no weight loss, treatment received and TNM were significantly related to survival in univariable analysis and in Cox's regression model. CONCLUSIONS: In our experience with advanced lung cancer subjected to anticancer therapy, the presence of weight loss is the variable with the greatest prognostic value, such that it may be useful to consider it routinely, along with activity level, to try to identify patients who will receive the most benefit from cytostatic treatment.


Subject(s)
Carcinoma, Bronchogenic/mortality , Carcinoma, Bronchogenic/pathology , Carcinoma, Non-Small-Cell Lung/mortality , Carcinoma, Non-Small-Cell Lung/pathology , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Weight Loss , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Neoplasm Staging , Prognosis , Retrospective Studies , Survival Rate
16.
Arch. bronconeumol. (Ed. impr.) ; 37(11): 477-481, dic. 2001.
Article in Es | IBECS | ID: ibc-903

ABSTRACT

OBJETIVOS: Se diseñó un estudio en carcinoma broncogénico no microcítico en estadios avanzados, con los siguientes objetivos: a) identificar factores pronósticos recogidos en el momento del diagnóstico, y b) precisar si la pérdida de peso es un parámetro útil para seleccionar a los sujetos que obtendrían un mayor beneficio del tratamiento oncológico. PACIENTES MÉTODOS: Se incluyó a 81 pacientes diagnosticados de carcinoma broncogénico no microcítico en estadios III-b y IV y con grado de actividad menor de 2 según ECOG. Las variables a estudiar fueron: edad, sexo, antecedentes de tabaquismo, comorbilidad, datos clínicos (pérdida de peso, disnea, síndrome de vena cava superior), parámetros de laboratorio (hemoglobina, albúmina sérica, linfocitos totales, lactatodeshidrogenasa sérica, calcemia y enzimas hepáticas), tipo histológico, grado de actividad, estadificación tumoral (TNM), tratamiento recibido y supervivencia en semanas. Se analizaron dos grupos: grupo general, formado por todos los pacientes, y grupo sin pérdida de peso, constituido por los sujetos en que estaba ausente este síntoma. Para el estudio estadístico y de supervivencia se utilizaron las siguientes pruebas: t de Student, 2, Kaplan-Meier, test de rangos logarítmos y modelos de regresión de Cox. RESULTADOS: La mediana de supervivencia fue de 29 semanas (rango: 21-37). En el grupo general presentaban una relación significativa con la supervivencia los siguientes parámetros: pérdida de peso, linfocitos totales, LDH sérica, TNM y grado de actividad. De éstos, sólo mantenían implicación pronóstica en el estudio multivariado de pérdida de peso (HR: 1,48 [1,14-1,92]; p = 0,002) y la TNM (HR: 0,72 [0,54-0,96]; p = 0,02). En el grupo sin pérdida de peso en el univariado tienen relación significativa el tratamiento recibido y la TNM, conservando ambas una correlación con el pronóstico al incluirlas en modelos de regresión de Cox. CONCLUSIONES: En nuestra experiencia, en carcinoma de pulmón en estadios avanzados subsidiarios de tratamiento oncológico, la pérdida de peso es la variable con mayor poder pronóstico, por lo que podría ser conveniente considerarla de manera rutinaria, conjuntamente con el grado de actividad, para intentar identificar a los pacientes que obtendrían un mayor beneficio del tratamiento citostático (AU)


Subject(s)
Middle Aged , Adult , Aged , Aged, 80 and over , Male , Female , Humans , Weight Loss , Survival Rate , Retrospective Studies , Prognosis , Carcinoma, Bronchogenic , Neoplasm Staging , Carcinoma, Non-Small-Cell Lung , Lung Neoplasms
20.
Arch Bronconeumol ; 33(5): 230-4, 1997 May.
Article in Spanish | MEDLINE | ID: mdl-9254169

ABSTRACT

We studied 162 patients with community-acquired pneumonia admitted for hospital treatment, in order to determine the utility of clinical and ancillary examinations for predicting etiology and guiding the most appropriate empirical treatment. Acute first appearance of symptoms, purulent expectoration, chest sounds indicating lung condensation, pleuritic chest pain and leukocytosis over 12,500/ml were statistically significant in differentiating typical pneumonias from those with atypical behavior patterns. The last two features were the most relevant according to multivariate analysis. We conclude that careful taking of case histories and basic blood testing continue to be relevant and must not be considered anachronistic for the differential diagnosis of community-acquired pneumonias.


Subject(s)
Hospitalization , Pneumonia, Bacterial/diagnosis , Pneumonia, Viral/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Community-Acquired Infections/classification , Community-Acquired Infections/diagnosis , Community-Acquired Infections/etiology , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Pneumonia, Bacterial/classification , Pneumonia, Bacterial/etiology , Pneumonia, Viral/classification , Pneumonia, Viral/etiology , Prognosis , Prospective Studies , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...